Pfizer to develop ARX-1796 which, if approved, has potential to be the first novel oral beta-lactamase inhibitor + antibiotic combination in more than 35 ... Oct 24
Convalescent plasma fails to reduce deaths or stop progression to severe disease ... Oct 24
The Bharat Biotech, which is into developing Covaxin - a vaccine candidate for COVID-19, on Friday said that it will now be conducting Phase III ... Oct 24
-Advertisements-